Key facts
- It has raised $1.3M; the latest was Later Stage VC ($1.3M) in Mar 2026.
- Notable investors include MassChallenge, Venture Kick, BioMérieux, Fongit, Quadia — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Plair (Medical devices)
- ·The full record, as it builds
Funding rounds
No funding rounds for Plair (Medical devices) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Plair (Medical devices)
Developer of air microbial monitoring device designed to provide instantaneous and autonomous environmental monitoring. The company's devices provide real-time pollen counting, airborne particle detection, single particle analysis, and measurement of allergens, pathogens, and pollutants, thereby enabling clients to get access to comprehensive data on allergens and other contaminants such as bacteria or fungi for enhanced forecasting and risk management.
- Sector
- Healthcare
- HQ
- Geneva, Switzerland
- Founded
- 2014
- Employees
- 17
- Website
- plair.ch/
- Ownership
- Privately Held (backing)
Plair (Medical devices) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Plair (Medical devices) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Plair (Medical devices) in its N-PORT filings yet. We sweep new filings monthly.